-
Something wrong with this record ?
18 years of face transplantation: Adverse outcomes and challenges
B. Longo, B. Pomahac, M. Giacalone, M. Cardillo, V. Cervelli
Language English Country Netherlands
Document type Systematic Review, Journal Article, Review
- MeSH
- Immune Tolerance MeSH
- Immunosuppression Therapy methods MeSH
- Humans MeSH
- Graft Rejection MeSH
- Facial Transplantation * adverse effects methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Systematic Review MeSH
BACKGROUND: Since the first procedure performed in 2005, face transplantation has been debated as viable approach for the treatment of severe craniofacial defects. Despite the benefits provided, the experience in face allotransplantation has brought to light a significant risk of complications, including allograft removal or loss, and mortality. The present study is intended to provide an updated review on complications and major challenges witnessed over 18 years of experience in the field. METHODS: A systematic review of PubMed, MEDLINE, Cochrane, Google, and Google Scholar databases on face transplantation was conducted according to PRISMA guidelines up to April 2023. Articles providing details on cases of face allograft loss, removal, and patient death were included. Online articles and media reports were assessed to include information not disclosed in peer-reviewed literature. Face transplant centers were contacted to have updated follow-up information on single-face transplant cases. RESULTS: The search yielded 1006 reports, of which 28 were included. On a total of 48 procedures performed in 46 patients, adverse outcomes were gleaned in 14 cases (29%), including seven allograft losses (14.6%), and the death of ten patients (21.7%). Chronic rejection was the leading cause of allograft loss, with a median time from transplant to irreversible rejection of 90 months (IQR 88.5-102). The main causes of death were infectious complications, followed by malignancies, non-compliance to immunosuppression, and suicide. The median time to death was 48.5 months (IQR 19-122). CONCLUSIONS: To the best of our knowledge, this is the first study providing a comprehensive review of adverse outcomes in face transplantation. Considering the high rate of major complications, the heterogeneity of cases and single-center approaches, and the absence of published standards of care, the development of a consensus by face transplant teams holds the key to the field's advancement.
Division of Plastic and Reconstructive Surgery Yale School of Medicine New Haven CT USA
National Transplants Center National Institute of Health Italian Ministry of Health Rome Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24003181
- 003
- CZ-PrNML
- 005
- 20240509113207.0
- 007
- ta
- 008
- 240220e20230915ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bjps.2023.09.043 $2 doi
- 035 __
- $a (PubMed)37879143
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Longo, Benedetto $u Chair of Plastic and Reconstructive Surgery, Department of Surgical Sciences, Tor Vergata University of Rome, Rome, Italy. Electronic address: benedetto.longo@uniroma2.it
- 245 10
- $a 18 years of face transplantation: Adverse outcomes and challenges / $c B. Longo, B. Pomahac, M. Giacalone, M. Cardillo, V. Cervelli
- 520 9_
- $a BACKGROUND: Since the first procedure performed in 2005, face transplantation has been debated as viable approach for the treatment of severe craniofacial defects. Despite the benefits provided, the experience in face allotransplantation has brought to light a significant risk of complications, including allograft removal or loss, and mortality. The present study is intended to provide an updated review on complications and major challenges witnessed over 18 years of experience in the field. METHODS: A systematic review of PubMed, MEDLINE, Cochrane, Google, and Google Scholar databases on face transplantation was conducted according to PRISMA guidelines up to April 2023. Articles providing details on cases of face allograft loss, removal, and patient death were included. Online articles and media reports were assessed to include information not disclosed in peer-reviewed literature. Face transplant centers were contacted to have updated follow-up information on single-face transplant cases. RESULTS: The search yielded 1006 reports, of which 28 were included. On a total of 48 procedures performed in 46 patients, adverse outcomes were gleaned in 14 cases (29%), including seven allograft losses (14.6%), and the death of ten patients (21.7%). Chronic rejection was the leading cause of allograft loss, with a median time from transplant to irreversible rejection of 90 months (IQR 88.5-102). The main causes of death were infectious complications, followed by malignancies, non-compliance to immunosuppression, and suicide. The median time to death was 48.5 months (IQR 19-122). CONCLUSIONS: To the best of our knowledge, this is the first study providing a comprehensive review of adverse outcomes in face transplantation. Considering the high rate of major complications, the heterogeneity of cases and single-center approaches, and the absence of published standards of care, the development of a consensus by face transplant teams holds the key to the field's advancement.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a transplantace obličeje $x škodlivé účinky $x metody $7 D054445
- 650 _2
- $a imunosupresivní léčba $x metody $7 D007165
- 650 _2
- $a imunologická tolerance $7 D007108
- 650 _2
- $a rejekce štěpu $7 D006084
- 655 _2
- $a systematický přehled $7 D000078182
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pomahac, Bohdan $u Division of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, CT, USA
- 700 1_
- $a Giacalone, Martina $u Chair of Plastic and Reconstructive Surgery, Department of Surgical Sciences, Tor Vergata University of Rome, Rome, Italy
- 700 1_
- $a Cardillo, Massimo $u National Transplants Center, National Institute of Health, Italian Ministry of Health, Rome, Italy
- 700 1_
- $a Cervelli, Valerio $u Chair of Plastic and Reconstructive Surgery, Department of Surgical Sciences, Tor Vergata University of Rome, Rome, Italy
- 773 0_
- $w MED00008968 $t Journal of plastic, reconstructive & aesthetic surgery $x 1878-0539 $g Roč. 87 (20230915), s. 187-199
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37879143 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240220 $b ABA008
- 991 __
- $a 20240509113201 $b ABA008
- 999 __
- $a ok $b bmc $g 2088837 $s 1212921
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 87 $c - $d 187-199 $e 20230915 $i 1878-0539 $m Journal of plastic, reconstructive & aesthetic surgery $n J Plast Reconstr Aesthet Surg $x MED00008968
- LZP __
- $a Pubmed-20240220